在Helicobacter pylori感染中进行抗生素耐药性,敏感性测试和管理
Ho-Yu Ng1, Wai K Leung2, Ka-Shing Cheung2,3
1School of Clinical Medicine, The University of Hong Kong, Hong Kong, China.
International journal of molecular sciences
|July 29, 2023
概括
优化Helicobacter pylori (H. pylori) 治疗需要了解抗生素耐药性机制和敏感性测试. 全球监测和管理对于有效的H. pylori根除至关重要.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 杆菌 (H. pylori) 感染影响全球数十亿人.
- 抗生素耐药性增加使H. pylori的根除复杂化.
- 新的测序技术有助于了解电阻.
研究的目的:
- 审查H. pylori抗生素耐药性的分子机制.
- 为了比较当前的抗生素敏感性测试方法.
- 为了评估经验与敏感性导向的H. pylori疗法.
主要方法:
- 关于H. pylori耐药性的最近研究的文献综述.
- 对抗生素耐药性的分子机制的分析.
- 对诊断和治疗策略的比较评估.
主要成果:
- 不同的分子机制驱动H. pylori抗生素耐药性.
- 测序方面的进步改善了敏感性测试.
- 受敏感性引导的治疗比经验方法更有前途.
结论:
- 有效的H. pylori治疗需要解决抗生素耐药性的问题.
- 常规监测和抗生素管理至关重要.
- 可持续的H. pylori管理需要全球合作.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
456
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
456
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
157
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
157
Peptic Ulcer Disease IV: Management
110
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
110
Urine Studies II: Urine Culture and Sensitivity Test
55
A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
55
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
465
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
465
Development of Antibiotic Resistance
41
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
41


